TABLE 3.
Demographic, Clinical, and Biological Features of Subjects With Type 2 Diabetes Included in the Study (N = 120)
| Variable | Mean ± SD or n (%) |
|---|---|
| Age, years | 60.60 ± 7.50 |
| Sex Male Female |
74 (61.7) 46 (38.3) |
| Duration of diabetes, years | 10.55 ± 7.15 |
| BMI, kg/m2 | 30.79 ± 4.54 |
| Waist circumference, cm Male Female |
107.50 ± 10.30 102.00 ± 11.30 |
| Systolic blood pressure, mmHg | 126.50 ± 11.08 |
| Diastolic blood pressure, mmHg | 61.80 ± 10.08 |
| A1C, % | 6.72 ± 0.64 |
| Glucose, mg/dL | 127.98 ± 34.79 |
| AST, units/L | 21.46 ± 9.27 |
| ALT, units/L | 27.79 ± 18.21 |
| TSH, mg/dL | 1.69 ± 1.02 |
| Total cholesterol, mg/dL | 156.97 ± 37.06 |
| HDL cholesterol, mg/dL Male Female |
43.73 ± 10.30 49.73 ± 11.30 |
| LDL cholesterol, mg/dL | 89.76 ± 29.88 |
| VLDL cholesterol, mg/dL | 29.18 ± 16.14 |
| Liver fat content >5% (MRI-PDFF) | 97 (80.8) |
| Triglycerides, mg/dL | 137.63 ± 72.28 |
| SWE LSM, kPa <6.0 (stage F0) 6.1–7.9 (stage F1) 8.0–9.4 (stage F2) 9.5–12.4 (stage F3) >12.5 (stage F4) |
62 (53.45) 38 (32.76) 7 (6.03) 7 (6.03) 2 (1.73) |
| SteatoTest grade S0 S0–S1 S1 S1–S2 S2 S2–S3 S3 |
25 (21.55) 13 (11.20) 16 (13.79) 24 (20.69) 14 (12.07) 5 (4.31) 19 (16.38) |
| NashTest 2 grade N0 N1 N2 N3 |
19 (16.38) 48 (41.38) 33 (28.45) 16 (13.79) |
| ActiTest grade A0 A1 A2 A3 |
89 (76.7) 24 (20.7) 1 (0.9) 2 (1.7) |
| FibroTest stage F0 F0–F1 F1 F1–F2 F2 F3 F3–F4 F4 |
48 (41.4) 15 (12.9) 9 (7.8) 25 (21.6) 4 (3.4) 11 (9.5) 2 (1.7) 2 (1.7) |